Cite
MLA Citation
Ignace Vergote et al.. “TP004/#1457 Trial in progress of engot-CX8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer.” International journal of gynecological cancer, vol. 32, n.d., p. A225. http://access.bl.uk/ark:/81055/vdc_100170500794.0x000027